Driven by the MEME token, Solana has surpassed XRP to become the fifth largest cryptocurrency by market capitalization.
Data shows that Solana (SOL) has replaced XRP as the fifth largest cryptocurrency by market capitalization, reaching a value of $35.1 billion, a 20-month high. This week, driven by rising asset prices and continuous inflows into DeFi protocols, Solana's total locked-in value (TVL) exceeded $1 billion for the first time since FTX crashed in November last year.
Trading volume on Solana's DEX has increased. On December 15th, Orca's trading volume reached $746 million, having only previously surpassed $100 million before November. Much of this increase in activity can be attributed to MEME tokens such as Bonk which currently have a market cap exceeding $1.2 billion.
The current trading price of SOL is $82.56 with a 24-hour increase of 11.8%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cross-chain atomic transactions between Ethereum mainnet and L2

US Stock Movement | US clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) enters the US stock market, shares drop over 10% after opening
According to Jinse Finance, Retension Pharmaceuticals (RTSN.US) debuted on the US stock market on Friday and fell over 10% to $10.77 at press time, with an IPO price of $12. Retension Pharmaceuticals is a US-based clinical-stage biopharmaceutical company focused on developing innovative drugs for the treatment of hypertension and other cardiovascular diseases. The company's core investigational drug, RTN-001, is a new generation phosphodiesterase 5 (PDE5) inhibitor, primarily targeting patients with uncontrolled or resistant hypertension, and is currently undergoing a Phase IIb clinical trial. This drug works by enhancing nitric oxide signaling in blood vessels to promote vasodilation and lower blood pressure. The exclusive global development license comes from French pharmaceutical giant Sanofi (SNY.US).
Chevron has suspended production operations at five facilities in the U.S. Gulf region.
Chevron (CVX.US) has evacuated personnel and shut down production operations at five facilities in the US Gulf region, while another four offshore platforms continue production.